Investigational Site Number 6430004

Ulyanovsk 432017

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease

Studies at this site

• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed